Mural Oncology plc

MURA · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$115,462$270,852$0$0
Short-Term Investments$28,923$0$0$0
Receivables$51$5,548$0$0
Inventory$0$0$0$0
Other Curr. Assets$8,481$937$4,817$4,239
Total Curr. Assets$152,917$277,337$4,817$4,239
Property Plant & Equip (Net)$14,498$24,150$28,933$30,871
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$1,979$258$0$0
Total NC Assets$16,477$24,408$28,933$30,871
Other Assets$0$0$0$0
Total Assets$169,394$301,745$33,750$35,110
Liabilities
Payables$2,056$5,973$2,966$10,586
Short-Term Debt$5,560$6,098$5,844$5,920
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$18,579$16,946$32,750$16,741
Total Curr. Liab.$26,195$29,017$41,560$33,247
LT Debt$2,462$8,911$13,542$19,386
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$235$0$304$356
Total NC Liab.$2,697$8,911$13,846$19,742
Other Liabilities$0$0$0$0
Cap. Leases$8,022$15,009$19,386$25,306
Total Liabilities$28,892$37,928$55,406$52,989
Equity
Pref Stock$0$0$0$0
Common Stock$171$167$0$0
Retained Earnings-$159,371-$30,857$0$0
AOCI$0$0$0$0
Other Equity$299,702$294,507-$21,656-$17,879
Total Equity$140,502$263,817-$21,656-$17,879
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$169,394$301,745$33,750$35,110
Net Debt-$107,440-$255,843$19,386$25,306